1 3 0 7 l e t t e r S Type 2 diabetes is a complex disease that is marked by the dysfunction of glucose and lipid metabolism. Hepatic insulin resistance is especially pathogenic in type 2 diabetes, as it dysregulates fasting and postprandial glucose tolerance and promotes systemic dyslipidemia and nonalcoholic fatty liver disease 1,2 . Mitochondrial dysfunction is closely associated with insulin resistance and might contribute to the progression of diabetes 3,4 . Here we used previously generated mice 5 with hepatic insulin resistance owing to the deletion of the genes encoding insulin receptor substrate-1 (Irs-1) and Irs-2 (referred to here as double-knockout (DKO) mice) to establish the molecular link between dysregulated insulin action and mitochondrial function. The expression of several forkhead box O1 (Foxo1) target genes increased in the DKO liver, including heme oxygenase-1 (Hmox1), which disrupts complex III and IV of the respiratory chain and lowers the NAD + /NADH ratio and ATP production. Although peroxisome proliferator-activated receptor- coactivator-1 (Ppargc-1) was also upregulated in DKO liver, it was acetylated and failed to promote compensatory mitochondrial biogenesis or function. Deletion of hepatic Foxo1 in DKO liver normalized the expression of Hmox1 and the NAD + /NADH ratio, reduced Ppargc-1 acetylation and restored mitochondrial oxidative metabolism and biogenesis. Thus, Foxo1 integrates insulin signaling with mitochondrial function, and inhibition of Foxo1 can improve hepatic metabolism during insulin resistance and the metabolic syndrome.
Irs1 and Irs2 are insulin receptor substrates, and their specific loss in the liver causes insulin resistance that progresses to hyperinsulinemia and diabetes 5, 6 . At 8 weeks of age, electron microscopy of liver sections from DKO mice revealed larger and lucent mitochondria that were distinctly different from the compact and electron-dense mitochondria in control liver (Fig. 1) . The DKO liver contained twofold larger and 50% fewer mitochondria per hepatocyte than control liver (Fig. 1a,d ,e), a substantial reduction that was confirmed by Mitotracker Green fluorescence and mitochondrial DNA (mtDNA) copy number ( Supplementary Fig. 1 ). We detected similar mitochondrial abnormalities in 4-week-old DKO mice before hyperglycemia developed 5 , suggesting that insulin resistance rather than hyperglycemia dysregulated mitochondrial structure and biogenesis ( Supplementary Fig. 2 ). Similar to DKO liver, liver sections from insulin-resistant leptin receptor-deficient (db/db) and leptindeficient (ob/ob) mice revealed larger and fewer mitochondria than liver sections from control mice by electron microscopy (Fig. 1b,c,f,g ). Therefore, direct (DKO mice) and indirect (db/db and ob/ob mice) genetic induction of insulin resistance was associated with dysregulated hepatic mitochondrial structure and biogenesis.
Foxo1 is a transcription factor that regulates genes controlling many hepatic functions, including glucose production and lipid metabolism 5, [7] [8] [9] [10] . Under physiological conditions insulin inactivates Foxo1 by Akt-stimulated phosphorylation 11 . Foxo1 was poorly phosphorylated in the liver of DKO, db/db and ob/ob mice ( Supplementary Fig. 3) . As a result, many hepatic genes were dysregulated in DKO liver, including several genes known to control mitochondrial function, biogenesis and dynamics (Supplementary Table 1 ). The concentrations of proteins that regulate mitochondrial fission and fusion-mitofusin-1, dynamin-1-like, fission-1 and dynactin-2-changed markedly in DKO, db/db and ob/ob mice, which was consistent with the accumulation of large and deformed mitochondria ( Fig. 1h-j) . As ablation of Foxo1 ameliorates the metabolic syndrome in DKO mice (triple knockout (TKO) mice) 5 , we tested whether mitochondria were restored to normal in TKO mice. Indeed, expression of the dysregulated genes in TKO liver was restored to the normal range (Supplementary Table 1) . Moreover, mitochondrial number and morphology and the expression of fusion and fission proteins were normalized in TKO mice and in db/db mice with Foxo1 deletion (db/db-Foxo1 −/− , referred to as db/db-FKO mice hereafter) (Fig. 1a,b,d-i) . Thus, Foxo1 inhibition, which normally occurs during insulin signaling, is required to achive proper mitochondrial biogenesis and morphology in mouse liver during states of insulin resistance.
To investigate the effect of direct or indirect genetic induction of insulin resistance upon mitochondrial function, we examined several metabolic parameters in insolated mitochondria from DKO, db/db and ob/ob liver. Mitochondrial respiration couples O 2 consumption Foxo1 integrates insulin signaling with mitochondrial function in the liver 1 3 0 8 volume 15 | number 11 | november 2009 nature medicine l e t t e r S with ATP production, which is measured as the respiratory control ratio (RCR)-the ratio of the oxygen consumption rate in the presence of ADP (state 3) to that in the absence of ADP (state 4) 12, 13 . In the DKO, db/db and ob/ob mitochondria, state 3 respiration was substantially disrupted, but state 4 respiration was unchanged compared to control mitochondria (Supplementary Fig. 4a) . Thus, the RCR was markedly lower in DKO, db/db and ob/ob mitochondria, showing that coupled mitochondrial respiration requires the Irs1 or Irs2 branch of the insulin signaling cascade (Fig. 2a) . The mitochondrial ATP production rate (APR) and cellular ATP concentration were also lower (Fig. 2b-c) . Consistent with these results, the mitochondrial membrane potential decreased about 40% in DKO mitochondria (data not shown). Moreover, the electron transport chain (ETC) activity measured by NADH oxidation decreased 32% in DKO liver and about 50% in db/db and ob/ob liver compared to the controls (Fig. 2d) . Consistent with the ETC deficiency, the NADH concentration increased and the NAD + concentration decreased, which lowered the NAD + /NADH ratio in the DKO, db/db and ob/ob liver (Fig. 2e,  Supplementary Fig. 4b ). Mitochondrial dysfunction also developed in the liver of 4-week-old DKO mice that were insulin resistant but normoglycemic ( Fig. 2f-h ). Mitochondrial function was restored in TKO liver and db/db-FKO liver, as revealed by the normal RCR, APR, ATP concentration, ETC and NAD + /NADH ratio ( Fig. 2a-e) . Thus, activated Foxo1 is central in dysregulating mitochondrial function during hepatic insulin resistance.
Ppargc-1α has a key role in mitochondrial biogenesis and function, as it induces the expression of nuclear respiration factor-1 (Nrf-1) and mitochondrial transcriptional factor A (Tfam) 14, 15 . The Ppargc1a level was 14-fold higher in DKO liver compared to the control liver (Supplementary Table 1) , and the Ppargc-1α l e t t e r S concentration increased by two-to threefold in DKO liver and in db/db and ob/ob liver ( Fig. 3a-c) . However, we did not observe the expected increase in Nrf-1 and Tfam expression, which can explain, at least in part, the dysregulated liver mitochondrial function in these mice ( Fig. 3a-c) . To determine why Ppargc-1α failed to promote mitochondrial biogenesis and function in the DKO liver, we measured the acetylation of Ppargc-1α. Acetylation inhibits Ppargc-1α function, and deacetylation is mediated by sirtuin-1 that is activated by NAD + (ref. 16 ). Consistent with the low NAD + / NADH ratio in DKO, db/db and ob/ob liver, Ppargc-1α was strongly acetylated ( Fig. 3a-c) . To corroborate that acetylation of Ppargc-1α contributed to the dysregulation of DKO mitochondria, we infected DKO mice with an adenovirus encoding wild-type Ppargc-1α or a mutant containing 13 lysine-to-arginine substitutions (R13-Ppargc-1α) that prevent acetylation and thus inactivation of Ppargc-1α 16 . The concentration of total Ppargc-1α increased substantially after adenoviral infection of wild-type and R13-Ppargc-1α; however, the abundance of acetylated Ppargc-1α was markedly lower upon infection with R13-Ppargc-1α (Fig. 3d) . Moreover, mitochondrial biogenesis and morphology were acutely restored by R13-Ppargc-1α but not by wild-type Ppargc-1α, suggesting that acetylation contributed to mitochondrial dysregulation in DKO mice ( Fig. 3e-g ).
To determine whether Foxo1-induced mitochondrial dysfunction leads to the inhibition of compensatory Ppargc-1α signaling, we investigated the integrity of the ETC. The ETC is composed of a series of sequentially acting electron carriers that consist of integral membrane proteins with prosthetic groups. Complexes I and II pass electrons from NADH and FADH 2 to complexes III and IV to generate the electrochemical proton gradient that drives ATP generation via complex V (ref 12). Complexes I, II and V, as indicated by the concentrations of NADH dehydrogenase subunit 6 (mt-Nd6), succinate dehydrogenase complex, subunit A (Sdha) and ATP synthase, H + transporting, mitochondrial F1 complex, alpha subunit 1 (Atp5a1), respectively, were apparently unchanged in DKO, db/db and ob/ob mitochondria (Fig. 4a,b) . By contrast, the essential components of the heme-dependent complexes III and IV-ubiquinol-cytochrome c reductase core protein I (Uqcrc1) and cytochrome c oxidase subunit 1 (mt-Co1), respectively-were downregulated 200% in DKO, db/db and ob/ob mitochondria compared to controls (Fig. 4a,b) .
Heme is an essential cofactor of mitochondrial oxidation, as it facilitates electron transport and ensures the expression, stability and function of complexes III and IV [17] [18] [19] . Our observation of defects in heme-dependent (Uqcrc1 and mt-Co1) but not in heme-independent (mt-Nd6, Sdha, and Atp5a1) components implied an alteration of the mitochondrial heme pool in the insulin-resistant livers. Indeed, the mitochondrial heme concentration was 35% lower in DKO liver and about 50% lower in db/db and ob/ob liver (Fig. 4c) . The reduction of heme content paralleled the upregulation of Hmox1 in both gene and protein levels (Supplementary Table 1 and Fig. 4d ). To determine whether the elevated expression of Hmox1 could be responsible for the diminished heme concentration, we treated the primary hepatocytes from DKO, db/db or ob/ob mice with short interfering RNA (siRNA) targeted against Hmox1 (Fig. 4e) . The siRNA treatment lowered the concentration of Hmox1 in DKO, db/db and ob/ob liver (Fig. 4e) . Moreover, suppression of Hmox1 largely normalized mitochondrial heme content in the isolated hepatocytes (Fig. 4f) . Consistent with these results, siRNA against Hmox1 restored ETC activity and the NAD/NADH ratio to the normal range in DKO, db/db and ob/ob hepatocytes (Fig. 4g,h) .
The deletion of hepatic Foxo1 lowered Hmox1 expression to the normal range and restored the expression of Uqcrc1 and mt-Co1 (Supplementary Table 1 and Fig. 4a-d) . To establish whether Hmox1 is a direct target of Foxo1, we prepared nuclear extracts from control, DKO and TKO livers for chromatin immunoprecipitation (ChIP) assays with antibody against Foxo1 and PCR analysis of Hmox1 promoter DNA. During insulin stimulation, the Foxo1 concentration was 1.5-fold higher in DKO nuclear extracts compared to control extracts (consistent with the absence of insulin action) but entirely absent from TKO extracts (Fig. 4i) . Accordingly, Hmox1 promoter DNA abundance was twofold higher in nuclear extracts from DKO liver compared to controls and completely undetectable in extracts from TKO liver (Fig. 4i) . 
e t t e r S
Our results reveal a complex network of genetic changes by which hepatic insulin resistance activates Foxo1 and dysregulates mitochondrial biogenesis and function. Foxo1 has a broad effect on hepatic gene expression, including Hmox1 expression through a direct interaction with its promoter. Hmox1 can dysregulate mitochondrial electron transport chain by decreasing the concentration of heme, which is required for the function and stability of complexes III and IV [17] [18] [19] . Thus, sustained Foxo1 activity decreased NADH oxidation, which decreases the concentration of NAD + in the livers of DKO, db/db and ob/ob mice. Because a decreased NAD + /NADH ratio inactivates the NAD-dependent deacetylase sirtuin-1-which is expressed normally in DKO, db/db and ob/ob liver (Supplementary Table 1 and Supplementary Fig. 5 )-Ppargc-1α is strongly acetylated and unable to promote the mitochondrial biogenesis and function that are crucial for normal oxidative phosphorylation and hepatic nutrient homeostasis 21 . In line with this, resveratrol, which can compensate for reduced NAD concentration by lowering the Michaelis constant of sirtuin-1 for NAD + (ref. 22) , markedly decreased the abundance of acetylated Ppargc-1α and restored mitochondrial function and biogenesis in the primary hepatocytes from DKO and ob/ob mice (Supplementary Fig. 6 ). Foxo1 was also hyperacetylated in DKO liver ( Supplementary Fig. 6) ; however, the effect of acetylation on Foxo1 activity remains controversial 23, 24 . Given that acetylation can stabilize and retain Foxo1 in the nucleus where it engages promyelocytic leukemia-associated protein (Pml) and undergoes activation 23, 24 , the redox inhibition of sirtuin-1 owing to mitochondrial dysfunction might augment Foxo1 activation and exacerbate its effects on metabolism in the insulin resistant liver. Thus, normalization of the NAD + /NADH ratio in DKO and db/db liver by deletion of Foxo1-or acute suppression of its target Hmox1-can indirectly reduce acetylation of Ppargc-1α and restore normal mitochondrial number, morphology and function (Fig. 4j) .
Foxo1 activation dysregulates several mitochondrial fusion and fission proteins in DKO, db/db and ob/ob mice, but whether Foxo1 has a direct effect on the expression of these genes is unknown. Regardless, deletion of Foxo1 normalizes the expression of these proteins and mitochondrial structure. The indirect inactivation of Ppargc-1α by acetylation could account for the deformed mitochondria, as the expression of R13-Ppargc-1α largely restored mitochondrial morphology and biogenesis in DKO liver. In skeletal muscle, Ppargc-1α increases mitofusin protein expression by directly stimulating its gene expression 25 .
One of the major complications in type 2 diabetes is the paradoxical accumulation of triglyceride and free fatty acids in the insulinresistant liver 26 . Considerable evidence shows that the maintenance of NAD + concentration is required for normal mitochondrial l e t t e r S β-oxidation 27, 28 . Pharmacological stimulation of mitochondrial NADH oxidation dramatically promotes fatty acid oxidation and ameliorates dyslipidemia, adiposity and fatty liver in obese mice 29 . Consistent with the decreased NAD + concentration, fatty acid oxidation was impaired and triglycerides accumulated in DKO liver (data not shown); however, deletion of Foxo1 from DKO liver normalized fatty acid oxidation and hepatic lipid content, concurrent with the restoration of mitochondrial function (data not shown). Thus, our results show how dysregulated insulin signaling can cause mitochondrial dysfunction that leads to metabolic disease. However, primary mitochondrial dysfunction can also promote fatty acid and triglyceride accumulation, which causes insulin resistance through the activation of serine kinases that inhibit Irs1 or Irs2 signaling 3 . In either case, partial inhibition of hepatic Foxo1 might be a good target to prevent the progression of a vicious cycle that causes metabolic disease.
MeTHODs
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
ONLINe MeTHODs
Mice. We generated the liver-specific DKO and TKO mice as described previously 5 . We purchased db/+ and ob/+ breeding pairs (Jackson Laboratories) to produce db/db and ob/ob mice. We generated db/db-FKO mice by crossbreeding db/+ mice with liver-specific Foxo1-knockout (FKO) mice 5 . We performed adenovirus infections via tail vein injection 16 . We housed all mice in plastic cages on a 12 h light-dark photocycle, giving them free access to water and food. We fasted the mice for 16 h and fed them with regular chow diet for 4 h before experiments. If not specified elsewhere, the control, DKO and TKO mice were 8-10 weeks old; the db/+, db/db, db/db-FKO, ob/+ and ob/ob mice were 16-20 weeks old. We performed mouse experiments according to procedures approved by the Children's Hospital Boston Institutional Animal Care and Use Committee.
Electron microscopy. We perfused the liver with 2% paraformaldehyde solution containing 2.5% glutaraldehyde, cut the perfused liver into small pieces (1 × 1 × 2 mm), fixed them in 5% glutaraldehyde at 4 °C overnight, postfixed them in 1% osmium tetroxide for 1 h at 25 °C, stained them in 2% uranyl acetate, dehydrated them in a series of ethanol dilutions (50-100%) and embedded them in epoxy resin (EMbed 812; Electron Microscopy Sciences). We stained the ultrathin sections (70 nm) with 2% uranyl acetate and lead citrate. We took five random sections from each liver and examined them in a Tecnai 12 BioTWIN electron microscope (FEI Co.), with ten random pictures taken from each section at various magnifications. We quantified mitochondrial number per cell was quantified by grid counting in a blinded fashion 21 . We measured mitochondrial area with Image 1.61 software (US National Institutes of Health) 30 .
Measurement of enzyme activities. We measured ETC activity of mitochondrial suspensions as described 30 , and mitochondrial ATP production rate with a luciferin-luciferase ATP monitoring reagent (Sigma-Aldrich) 31 . For the determination of steady-state ATP content in the liver, we prepared samples as reported previously 32 .
Oxygen consumption assays. We measured oxygen consumption with a Clark type polarographic oxygen probe (Micrometrix Corp.) as described previously 13, 33 . RCR was calculated as the ratios of the rate of oxygen uptake in state 3 to that in state 4.
Pyridine nucleotide measurements. We analyzed the pyridine nucleotides (NAD + and NADH) in liver with EnzyChrom assay kits according to the manufacturer's instructions (BioAssay Systems).
Chromatin immunoprecipitation assay.
We performed ChIP assay as described previously 34 . Briefly, we minced mouse liver in cold PBS and passed the solution through a 21-gauge needle. We cross-linked the minced tissue with 1% formaldehyde in PBS for 15 min with constant shaking (25 °C). We performed the downstream assay with a ChIP assay kit according to the manufacturer's instructions (Upstate Biotechnology). We analyzed DNA by real-time PCR using an iQ SYBR Green Supermix (Bio-Rad). Forward and reverse primers for Hmox1 promoter were 5′-TGTGCCATCACTACCCAGAA-3′ and 5′-AG CAGGGTAAGGCTTGGAAT-3′ or 5′-TGGTTCCCAACTCACAGAGATCT-3′ and 5′-GGGTAGTGATGGCACATTCCTT-3′ (BioPolymers).
Immunoprecipitation and western blot. We performed immunoprecipitation and immunoblotting as described previously 5 . Protease inhibitor cocktail for lysate preparation was from Sigma, protein A/G agarose for immunoprecipitaiton from Santa Cruz and nitrocellulose or polyvinylidene fluoride membranes from Amersham Pharmacia. We probed samples with antibodies and detected with horseradish peroxidase-conjugated secondary antibodies using ECL detection system (Perkin Elmer). The antibodies specific for Ppargc-1α (sc-13067), NRF-1 (sc-33771 or ab34682), Tfam (sc-28200), mitofusin-1 (sc-50330), mitofusin-2 (sc-50331) and fission-1 (sc-48865) were from Santa Cruz or Abcam. Monoclonal antibodies specific for complex I (mt-Nd6), complex II (Sdha), complex III (Uqcrc1), complex IV (mt-Co1), and complex V (Atp5a1) were from Molecular Probes; antibodies to Foxo1 (9454S), Foxo1 phosphorylated on Thr24 (9464S) and β-actin (4970L) were from Cell Signaling Technology. Antibody to dynamin-1-like (NB110-55237) was from Novus Biologicals; dynactin-2 specific antibody (10031-2-AP) was from Proteintech Group; and lysine acetylation-specific antibody (05-515) was from Upstate. We analyzed and quantified images with Image Quant TL software (Amersham Biosciences). To focus on insulin effects after refeeding stimulation, we presented the data from refed mice only.
Statistical analyses.
All results are expressed as means ± s.d. and are analyzed by analysis of variance to determine P values; P < 0.05 was considered statistically significant. 
